FDAFDA · Food and drugs·Recall number D-1473-2022
Neomycin Sulfate Tablets, USP 500 mg , 100-count bottles, Rx only, Distributed by: TEVA PHARMACEUTICALS USA, INC North Wales, PA 19454, NDC 0093-1177-01
Published September 7, 2022 · Recall initiated: August 23, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: A foreign matter identified as teflon was found in the Active Pharmaceutical Ingredient (API) used in the manufacture of Neomycin Sulfate Tablets, USP 500 mg.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- NEOMYCIN SULFATE
- Manufacturer
- Teva Pharmaceuticals USA Inc
- Distributor
- Nationwide within the United States
- UPC
- 0300931177018
- Lot
- Lot #: 3007830, 3007746, 3007829, Exp. Date 10/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.